A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds can keep taking them in the weeks before a surgery. Concerns had arisen because the drugs, which include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), liraglutide (Saxenda) and dulaglutide (Trulicity), can…  read on >  read on >

A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’s disease are climbing sharply, according to research led by Amanda Gusovsky, of…  read on >  read on >

Big surges in new autism diagnoses among young adults, as well a rise in diagnoses for girls and young women, have driven a near-tripling of U.S. autism cases in just over a decade, researchers report. Data on over 12 million patients enrolled in major U.S. health care systems found that between 2011 and 2022 the…  read on >  read on >

A lack of health insurance coverage raises the risk that cancers among Black and Hispanic Americans will be caught too late, a new study suggests. Being uninsured accounts for a significant proportion of racial and ethnic disparities in cancers that are only detected at a later, more life-threatening stage, researchers found. “Securing health insurance for…  read on >  read on >

People who regularly use marijuana experience changes in their brain structure and function, but it’s not clear that cannabis is the cause, a new study finds. Researchers found specific differences in the brains of people who’d ever used weed, particularly in areas densely packed with cannabinoid receptors. However, genetic analysis couldn’t pin down any specific…  read on >  read on >